Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics
- PMID: 3490520
- DOI: 10.1093/infdis/154.5.792
Type I beta-lactamases of gram-negative bacteria: interactions with beta-lactam antibiotics
Abstract
The interaction of type I beta-lactamases with diverse beta-lactam compounds representing cephalosporins, cephamycins, penicillins, penams, penems, carbapenems, monobactams, and clavams was examined by using various Enterobacteriaceae and Pseudomonas aeruginosa as sources of the enzymes. The ability of a given drug to reversibly induce beta-lactamase was unrelated to its ability to select mutants stably derepressed for beta-lactamase production. Imipenem was one of the most-potent enzyme inducers, yet it did not select derepressed mutants. Many of the newer cephalosporins were poor enzyme inducers but readily selected derepressed mutants. Resistance to hydrolysis did not predict a drug's inhibitory activity against derepressed mutants. The activity of the penems, penams, and carbapenems was least affected by derepression of beta-lactamase, whereas the activity of anionic cephalosporins and aztreonam was most affected.
Similar articles
-
Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.Antimicrob Agents Chemother. 1998 May;42(5):1168-75. doi: 10.1128/AAC.42.5.1168. Antimicrob Agents Chemother. 1998. PMID: 9593145 Free PMC article.
-
Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.Eur J Clin Microbiol. 1987 Aug;6(4):439-45. doi: 10.1007/BF02013107. Eur J Clin Microbiol. 1987. PMID: 3311738 Review.
-
Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.J Antimicrob Chemother. 1997 Jan;39(1):31-4. doi: 10.1093/jac/39.1.31. J Antimicrob Chemother. 1997. PMID: 9044025
-
The ability of beta-lactam antibiotics to select mutants with derepressed beta-lactamase synthesis from Citrobacter freundii.J Antimicrob Chemother. 1995 Sep;36(3):483-96. doi: 10.1093/jac/36.3.483. J Antimicrob Chemother. 1995. PMID: 8830012
-
[Broad-spectrum beta-lactamases in Gram-negative bacteria].Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2741-5. Tidsskr Nor Laegeforen. 2008. PMID: 19079424 Review. Norwegian.
Cited by
-
Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.Antimicrob Agents Chemother. 1988 Sep;32(9):1443-5. doi: 10.1128/AAC.32.9.1443. Antimicrob Agents Chemother. 1988. PMID: 3143306 Free PMC article.
-
Beta-lactamase production in members of the family Enterobacteriaceae and resistance to beta-lactam-enzyme inhibitor combinations.Antimicrob Agents Chemother. 1990 Apr;34(4):622-7. doi: 10.1128/AAC.34.4.622. Antimicrob Agents Chemother. 1990. PMID: 2344169 Free PMC article.
-
Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01771-19. doi: 10.1128/AAC.01771-19. Print 2020 Feb 21. Antimicrob Agents Chemother. 2020. PMID: 31818817 Free PMC article.
-
Development of resistance by Enterobacter cloacae during therapy of pulmonary infections in intensive care patients.Clin Investig. 1994 Dec;72(12):1015-9. doi: 10.1007/BF00577747. Clin Investig. 1994. PMID: 7711407
-
Effect of β-lactam antibiotic resistance gene expression on the radio-resistance profile of E. coli O157:H7.Heliyon. 2018 Dec 1;4(12):e00999. doi: 10.1016/j.heliyon.2018.e00999. eCollection 2018 Dec. Heliyon. 2018. PMID: 30534620 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical